17 documents found, page 1 of 2
World Heart Federation Cholesterol Roadmap: The Portuguese case
Abreu, A; Dores, H; Gonçalves, L; Franco, F; Silveira, C; Proença, G; Teresa Timóteo, A; Cardim, N; Pedro, M; Fiuza, M; Ferreira, D; Bento, LAtherosclerotic cardiovascular disease (ASCVD) remains the major cause of premature death and disability; effective cardiovascular (CV) risk prevention is fundamental. The World Heart Federation (WHF) Cholesterol Roadmap provides a framework for national policy development and aims to achieve ASCVD prevention. At the invitation of the WHF, a group of experts from the Portuguese Society of Cardiology (SPC), addr...
The Portuguese Journal of Cardiology: Is the glass half full or half empty?
Donato, H; Cardim, N
Polypill use for the prevention of cardiovascular disease: a position paper
Araújo, F; Caldeira, D; Aguiar, C; Antunes, JP; Cardim, N; Cunha, V; Fonseca, L; Moura, JP; Paixão-Dias, VM; Ribeiro, H; Cruz, VT; Gavina, CCardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider t...
The Portuguese Journal of Cardiology: Is the glass half full or half empty?
Donato, H; Cardim, N
Polypill use for the prevention of cardiovascular disease: A position paper
Araújo, F; Caldeira, D; Aguiar, C; Antunes, JP; Cardim, N; Cunha, V; Fonseca, L; Moura, JP; Paixão-Dias, VM; Ribeiro, H; Tedim Cruz, V; Gavina, CCardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider t...
The impact factor addiction: Facts and fiction
Donato, H; Cardim, N
The amount of late gadolinium enhancement outperforms current guideline-recomme...
Freitas, P; Ferreira, AM; Arteaga-Fernández, E; de Oliveira Antunes, M; Mesquita, J; Abecasis, J; Marques, H; Saraiva, C; Matos, DN; Rodrigues, RBACKGROUND: Identifying the patients with hypertrophic cardiomyopathy (HCM) in whom the risk of sudden cardiac death (SCD) justifies the implantation of a cardioverter-defibrillator (ICD) in primary prevention remains challenging. Different risk stratification and criteria are used by the European and American guidelines in this setting. We sought to evaluate the role of cardiovascular magnetic resonance (CMR) ...
The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results
Cardim, N; Brito, D; Lopes, L; Freitas, A; Araújo, C; Belo, A, et al.INTRODUCTION: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. METHODS: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. RESULTS: A total of 29 centers participated and 1042 patients were recruited. Four cente...
The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results
Cardim, N; Brito, D; Lopes, LR; Freitas, A; Araújo, C; Belo, A; Gonçalves, L; Mimoso, J; Olivotto, I; Elliott, P; Madeira, HIntroduction: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. Methods: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. Results: A total of 29 centers participated and 1042 patients were recruited. Four cente...
Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from C...
Fiarresga, A; Mata, M; Cavaco-Gonçalves, S; Selas, M; Simões, I; Oliveira, E; Carrapiço, B; Cardim, N; Cabral, J; Cruz Ferreira, R; Silva, CBACKGROUND: Mesenchymal stem/stromal cells have unique properties favorable to their use in clinical practice and have been studied for cardiac repair. However, these cells are larger than coronary microvessels and there is controversy about the risk of embolization and microinfarctions, which could jeopardize the safety and efficacy of intracoronary route for their delivery. The index of microcirculatory resis...